Researchers targeting the cAMP specific PDE4 have demonstrated that elevated cAMP/PKA signaling increases apoptosis and decreases platinum resistance and enhances platinum sensitivity in ovarian cancer cells [22, 23]. Here, PDE4A is linked to ovarian carcinoma.